Sage Journals: Discover world-class research

Abstract

Objectives:

This study aimed to explore the levels and associations among depressive symptoms, perceived stress, and proinflammatory cytokines (interleukin-1β, interleukin-6, and tumor necrosis factor-α) in treatment-naïve patients with breast cancer.

Methods:

A cross-sectional study with one case and two control groups. Patients with breast cancer, matched patients with depression, and matched healthy women completed questionnaires and blood collection between May 2015 and March 2017. Data were analyzed using the general linear model and linear regression model.

Results:

The severity of depressive symptoms and perceived stress among patients with breast cancer was significantly higher than that in healthy controls and lower than those in patients with depression. Interleukin-1β was lower in patients with breast cancer than the other two groups. Perceived stress was independently and positively associated with depressive symptoms in patients with breast cancer. There were no significant associations between cytokines and depressive symptoms.

Conclusion:

Women with breast cancer experienced increased perceived stress prior to anticancer treatment, which was a strong contributor to severe symptoms of depression. Results emphasize the need to screen and identify patients with high perceived stress shortly after the disclosure of the diagnosis of breast cancer. Further research in larger sample is needed to investigate the relationship between proinflammatory cytokines and depressive symptoms.

Keywords

breast cancer cytokines depression depressive symptoms inflammation stress

Get full access to this article

View all access options for this article.

References

Andersen

B. L.

DeRubeis

R. J.

Berman

B. S.

Gruman

Champion

V. L.

Massie

M. J.

Holland

J. C.

Partridge

A. H.

Bak

Somerfield

M. R

., & American Society of Clinical Oncology. (2014). Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. Journal of Clinical Oncology, 32(15), 1605–1619. https://doi.org/10.1200/JCO.2013.52.4611

Antoni

M. H.

(2013). Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain, Behavior, and Immunity, 30(Suppl), S88–98. https://doi.org/10.1016/j.bbi.2012.05.009

Bekhbat

Neigh

G. N.

(2018). Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety. Brain, Behavior, and Immunity, 67, 1–12. https://doi.org/10.1016/j.bbi.2017.02.006

Bouchard

L. C.

Antoni

M. H.

Blomberg

B. B.

Stagl

J. M.

Gudenkauf

L. M.

Jutagir

D. R.

Diaz

Lechner

Glück

Derhagopian

R. P.

Carver

C. S.

(2016). Postsurgical depressive symptoms and proinflammatory cytokine elevations in women undergoing primary treatment for breast cancer. Psychosomatic Medicine, 78(1), 26–37. https://doi.org/10.1097/PSY.0000000000000261

Bower

J. E.

Ganz

P. A.

Irwin

M. R.

Kwan

Breen

E. C.

Cole

S. W.

(2011). Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? Journal of Clinical Oncology, 29(26), 3517–3522. https://doi.org/10.1200/JCO.2011.36.1154

Brown

G. W.

Harris

T. O. E.

(1989). Life events and illness ( Brown

G. W.

, Eds.). Guilford Press.

Chen

Zheng

Baade

P. D.

Zhang

Zeng

Bray

Jemal

X. Q.

(2016). Cancer statistics in China, 2015. CA Cancer Journal for Clinicians, 66(2), 115–132. https://doi.org/10.3322/caac.21338

Chen

Zheng

Chen

Shu

X. O.

(2009). Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncologica, 48(8), 1128–1136. https://doi.org/10.3109/02841860903188650

Cohen

Williamson

(1988). Perceived stress in a probability sample of the United States. In Spacapam

Oskamp

(Eds.), The social psychology of health: Claremont symposium on applied social psychology. Sage.

10.

De Sanctis

Agolli

Visco

Monaco

Muni

Spagnoli

Campanella

Valeriani

Minniti

Osti

M. F.

Amanti

Pellegrini

Brunetti

Costantini

Alfò

Torrisi

M. R.

Marchetti

Enrici

R. M.

(2014). Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy. BioMed Research International, 2014, 523568. https://doi.org/10.1155/2014/523568

11.

Forget

Rengger

Berliere

De Kock

(2014). Inflammatory scores are not interchangeable during the perioperative period of breast cancer surgery. International Journal of Surgery, 12(12), 1360–1362. https://doi.org/10.1016/j.ijsu.2014.11.008

12.

Galecki

Talarowska

(2018). Inflammatory theory of depression. Psychiatria Polska, 52(3), 437–447. https://doi.org/10.12740/PP/76863

13.

Haapakoski

Mathieu

Ebmeier

K. P.

Alenius

Kivimaki

(2015). Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain, Behavior, and Immunity, 49, 206–215. https://doi.org/10.1016/j.bbi.2015.06.001

14.

Hammen

(2018). Risk factors for depression: An autobiographical review. Annual Review of Clinical Psychology, 14, 1–28. https://doi.org/10.1146/annurev-clinpsy-050817-084811

15.

Hammen

C. L.

(2015). Stress and depression: old questions, new approaches. Current Opinion in Psychology, 4, 80–85.

16.

Han

T. J.

Felger

J. C.

Lee

Mister

Miller

A. H.

Torres

M. A.

(2016). Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy. Psychooncology, 25(2), 187–193. https://doi.org/10.1002/pon.3831

17.

Harkness

K. L.

Alavi

Monroe

S. M.

Slavich

G. M.

Gotlib

I. H.

Bagby

R. M.

(2010). Gender differences in life events prior to onset of major depressive disorder: the moderating effect of age. Journal of Abnormal Psychology, 119(4), 791–803. https://doi.org/10.1037/a0020629

18.

R. T.

Kwan

T. T.

Cheung

I. K.

Chan

C. K.

P. H.

Yip

P. S.

Luk

M. Y.

Chan

C. L.

(2015). Association of fatigue with perceived stress in Chinese women with early stage breast cancer awaiting adjuvant radiotherapy. Stress Health, 31(3), 214–221. https://doi.org/10.1002/smi.2548

19.

Jasionowska

Talarowska

Kalinka

Skiba

Szemraj

Mikolajczyk

Galecki

(2019). Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: A prospective study. Croatian Medical Journal, 60(2), 166–173. https://doi.org/10.3325/cmj.2019.60.166

20.

Jehn

C. F.

Flath

Strux

Krebs

Possinger

Pezzutto

Luftner

(2012). Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer. Breast Cancer Research and Treatment, 136(3), 789–794. https://doi.org/10.1007/s10549-012-2311-2

21.

H. B.

Kang

E. C.

Jeon

D. W.

Kim

T. H.

Moon

J. J.

Kim

S. J.

Choi

J. M.

Jung

D. U.

(2018). Associations among plasma stress markers and symptoms of anxiety and depression in patients with breast cancer following surgery. Psychiatry Investigation, 15(2), 133–140. https://doi.org/10.30773/pi.2017.07.26

22.

Kim

S. Y.

Kim

J. M.

Kim

S. W.

Shin

I. S.

Park

M. H.

Yoon

J. H.

Choi

Yoon

J. S.

(2012). Associations between plasma cytokines and depressive mood in patients with breast cancer. The International Journal of Psychiatry in Medicine, 43(1), 1–17. https://doi.org/10.2190/PM.43.1.a

23.

Kroenke

Spitzer

R. L.

Williams

J. B.

(2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.

24.

Krohn

Listing

Tjahjono

Reisshauer

Peters

Klapp

B. F.

Rauchfuss

(2011). Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy. Supportive Care in Cancer, 19(9), 1303–1311. https://doi.org/10.1007/s00520-010-0946-2

25.

Lee

Song

Lee

Kim

J. B.

Lee

M. S.

(2020). Prospective study on cytokine levels in medication-naive adolescents with first-episode major depressive disorder. Journal of Affective Disorders, 266, 57–62. https://doi.org/10.1016/j.jad.2020.01.125

26.

Leung

D. Y.

Lam

T. H.

Chan

S. S.

(2010). Three versions of Perceived Stress Scale: Validation in a sample of Chinese cardiac patients who smoke. BMC Public Health, 10, 513. https://doi.org/10.1186/1471-2458-10-513

27.

Gao

L. X.

Zhu

S. Y.

Cao

F. L.

(2017). Breast-related stereotype threat contributes to a symptom cluster in women with breast cancer. Journal of Clinical Nursing, 26(9–10), 1395–1404. https://doi.org/10.1111/jocn.13698

28.

Maske

U. E.

Buttery

A. K.

Beesdo-Baum

Riedel-Heller

Hapke

Busch

M. A.

(2016). Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany. Journal of Affective Disorders, 190, 167–177. https://doi.org/10.1016/j.jad.2015.10.006

29.

Mausbach

B. T.

Schwab

R. B.

Irwin

S. A.

(2015). Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment, 152(2), 239–246. https://doi.org/10.1007/s10549-015-3471-7

30.

Moriarty

A. S.

Gilbody

McMillan

Manea

(2015). Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): A meta-analysis. General Hospital Psychiatry, 37(6), 567–576. https://doi.org/10.1016/j.genhosppsych.2015.06.012

31.

Muller

Krause

Barth

Myint

A. M.

Weidinger

Stettinger

Zill

Drexhage

Schwarz

M. J.

(2019). Childhood adversity and current stress are related to pro- and anti-inflammatory cytokines in major depression. Journal of Affective Disorders, 253, 270–276. https://doi.org/10.1016/j.jad.2019.04.088

32.

Ni Eochagain

Burns

Riedel

Sessler

D. I.

Buggy

D. J.

(2018). The effect of anaesthetic technique during primary breast cancer surgery on neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and return to intended oncological therapy. Anaesthesia, 73(5), 603–611. https://doi.org/10.1111/anae.14207

33.

Park

E. M.

Gelber

Rosenberg

S. M.

Seah

D. S. E.

Schapira

Come

S. E.

Partridge

A. H.

(2018). Anxiety and depression in young women with metastatic breast cancer: a cross-sectional study. Psychosomatics, 59(3), 251–258. https://doi.org/10.1016/j.psym.2018.01.007

34.

Pertl

M. M.

Hevey

Boyle

N. T.

Hughes

M. M.

Collier

O’Dwyer

A. M.

Harkin

Kennedy

M. J.

Connor

T. J.

(2013). C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. Brain, Behavior, and Immunity, 34, 108–119. https://doi.org/10.1016/j.bbi.2013.07.177

35.

Popoola

A. O.

Adewuya

A. O.

(2012). Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psychooncology, 21(6), 675–679. https://doi.org/10.1002/pon.1968

36.

Qiu

Yang

Chen

Gao

Liu

Shi

Xie

(2012). Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psychooncology, 21(12), 1331–1337. https://doi.org/10.1002/pon.2075

37.

Rebholz

W. N.

Cash

Zimmaro

L. A.

Bayley-Veloso

Phillips

Siwik

Chagpar

A. B.

Dhabhar

F. S.

Spiegel

Bell

B. S.

Sephton

S. E.

(2018). Distress and quality of life in an ethnically diverse sample awaiting breast cancer surgery. Journal of Health Psychology, 23(11), 1438–1451. https://doi.org/10.1177/1359105316659916

38.

J. A.

Yeh

D. C.

Chang

C. C.

Lin

T. C.

Lai

C. H.

P. Y.

Y. F.

Chen

V. C.

Wang

T. N.

Gossop

(2017). Depression and family support in breast cancer patients. Neuropsychiatric Disease and Treatment, 13, 2389–2396. https://doi.org/10.2147/NDT.S135624

39.

Torres

M. A.

Pace

T. W.

Liu

Felger

J. C.

Mister

Doho

G. H.

Kohn

J. N.

Barsevick

A. M.

Long

Miller

A. H.

(2013). Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer, 119(11), 1951–1959. https://doi.org/10.1002/cncr.28003

40.

Vodermaier

Linden

Rnic

Young

S. N.

Ditsch

Olson

(2014). Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer. Breast Cancer Research and Treatment, 143(2), 373–384. https://doi.org/10.1007/s10549-013-2795-4

41.

Walker Ii

W. H.

Borniger

J. C.

Surbhi Zalenski

A. A.

Muscarella

S. L.

Fitzgerald

J. A.

Zhang

Gaudier-Diaz

M. M.

DeVries

A. C

. (2017). Mammary tumors induce central pro-inflammatory cytokine expression, but not behavioral deficits in Balb/C Mice. Scientific Reports, 7(1), 8152. https://doi.org/10.1038/s41598-017-07596-9

42.

Wang

B. D

. (2013). A study of the application of PHQ-9 and GAD-7 in malignant tumor population. Central South University.

43.

Xiao

Miller

A. H.

Felger

Mister

Liu

Torres

M. A.

(2017). Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors. Psychological Medicine, 47(10), 1733–1743. https://doi.org/10.1017/S0033291717000150

44.

Yen

J. Y.

C. H.

Yen

C. F.

Yang

M. J.

C. Y.

Juan

C. H.

Hou

M. F

. (2006). Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan. Psychiatry and Clinical Neurosciences, 60(2), 147–153. https://doi.org/10.1111/j.1440-1819.2006.01479.x

Association of Depressive Symptoms with Perceived Stress and Proinflammatory Cytokines in Treatment-Naïve Patients with Breast Cancer

Abstract

Objectives:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References